Swapnil Rajpathak Current Interview

Diabetes in Control speaks with top endocrinologists and other medical professionals to bring you the latest in diabetes news and research. This week, we have another exclusive interview from the ADA 2017 Scientific Sessions in San Diego, CA.

Dr. Swapnil N. Rajpathak is the Executive Director of the Center for Observational and Real World Evidence at Merck. After completing medical school and clinical training in Mumbai, India, he received his Masters in Public Health from the George Washington University (2001) and a doctoral degree with double majors in
Epidemiology and Nutrition from Harvard University (2005). Following his training, Dr. Rajpathak was appointed as a faculty at the Albert Einstein College of Medicine in New York in the departments of Medicine
(Endocrinology) and of Epidemiology and Population Health. After six years of academic research, Dr.
Rajpathak transitioned to Merck.

Featured videos include:

Pt.1: DPP-4 Inhibitors And Hypoglycemia

Pt.2: Cost Effectiveness Of DPP-4 Inhibitors

Pt.3: Defining Hypoglycemia For DPP-4 Inhibitors Research

Pt.4: ADA 2017 And Real World Study Guidelines

Pt.5: Future Real World Study Research For Merck

or view the complete interview here: Complete Interview.

To read the transcript of the full interview, click here.